Работайте офлайн с приложением Player FM !
Michael Demurjian - CEO, Aspargo Labs - Improving Patient Experience With Novel Formulations & Technology
Manage episode 451361312 series 2835025
Michael Demurjian is CEO And Chairman of Aspargo Labs ( https://aspargolabs.com/ ), which he co-founded in 2019, which is a distinguished pharmaceutical and med-tech company committed to developing innovative oral spray formulations and drug delivery systems.
Mr. Demurjian brings extensive experience across finance, manufacturing, sales & marketing, logistics, and general management. He has experience in taking companies public, raising funds in public and private markets with both retail and institutional investors.
Prior to Aspargo Labs, Mr. Demurjian served as COO, CFO and member of the Board of Directors of Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have tolerable toxicity profiles. At Tyme, Mr. Demurjian was instrumental in raising over 50 million dollars and obtaining a public listing on NASDAQ. He also served as CEO of Luminant Biosciences, an oncology research company studying metabolic pathways to destroying cancer cells.
Throughout his career, Mr. Demurjian has successfully completed strategic transactions with G.E., Stryker, Black & Decker Corp., and Crane Cams.
Mr. Demurjian currently sits on the Board of Directors of the Susan G. Komen Foundation, the NYU board of advisors and has served in the past on the Board of Directors of Luminant Bio., Mikronite Tech & KCC.
#Aspargo #MichaelDemurjian #DrugFormulation #PatientCompliance #LiquidOralSuspensions #Bioavailability #Pharmacokinetics #Pharamcodynamics #Pharmacology #Adherence #Sildenafil #Dimenhydrante #Statins #Metformin #PotassiumIodide #Antiemetics #Dysphagia #MeteredDose #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research
569 эпизодов
Manage episode 451361312 series 2835025
Michael Demurjian is CEO And Chairman of Aspargo Labs ( https://aspargolabs.com/ ), which he co-founded in 2019, which is a distinguished pharmaceutical and med-tech company committed to developing innovative oral spray formulations and drug delivery systems.
Mr. Demurjian brings extensive experience across finance, manufacturing, sales & marketing, logistics, and general management. He has experience in taking companies public, raising funds in public and private markets with both retail and institutional investors.
Prior to Aspargo Labs, Mr. Demurjian served as COO, CFO and member of the Board of Directors of Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have tolerable toxicity profiles. At Tyme, Mr. Demurjian was instrumental in raising over 50 million dollars and obtaining a public listing on NASDAQ. He also served as CEO of Luminant Biosciences, an oncology research company studying metabolic pathways to destroying cancer cells.
Throughout his career, Mr. Demurjian has successfully completed strategic transactions with G.E., Stryker, Black & Decker Corp., and Crane Cams.
Mr. Demurjian currently sits on the Board of Directors of the Susan G. Komen Foundation, the NYU board of advisors and has served in the past on the Board of Directors of Luminant Bio., Mikronite Tech & KCC.
#Aspargo #MichaelDemurjian #DrugFormulation #PatientCompliance #LiquidOralSuspensions #Bioavailability #Pharmacokinetics #Pharamcodynamics #Pharmacology #Adherence #Sildenafil #Dimenhydrante #Statins #Metformin #PotassiumIodide #Antiemetics #Dysphagia #MeteredDose #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research
569 эпизодов
Все серии
×Добро пожаловать в Player FM!
Player FM сканирует Интернет в поисках высококачественных подкастов, чтобы вы могли наслаждаться ими прямо сейчас. Это лучшее приложение для подкастов, которое работает на Android, iPhone и веб-странице. Зарегистрируйтесь, чтобы синхронизировать подписки на разных устройствах.